Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients
Clinical trial NCT04336124 · COMPLETED
Trial details
- NCT number
- NCT04336124
- Sponsor
- TaiRx, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-25
- Primary completion
- 2021-02-08
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.